Rocket Pharma (NASDAQ: RCKT) is a fully-integrated, clinical-stage company advancing numerous gene therapies that could cure rare childhood diseases. Rocket places enormous value on people and takes team member progress and well-being just as seriously as the progress and well-being of its pipeline. We are looking for hands-on team players that enjoy collaborating with colleagues who share a passion for seeking gene therapy cures for devastating diseases and making a difference for patients. Become an integral part of a small, highly productive team and help grow an entrepreneurial, scientifically driven organization that is increasingly recognized as a leading biotechnology innovator. In addition to a competitive compensation package featuring a generous 401K match and stock options, positions include excellent health benefits.
For more information, please visit www.rocketpharma.com.
Twitter: https://bit.ly/2O28aHx
YouTube: https://bit.ly/3iNSXIu
|
|
|
|
|
201-500 employees
View all Rocket Pharmaceuticals employees
|
|
|
Biotechnology
|
|
|
646-440-9100
|
|
|
9 Cedar Brook Dr, Cranbury, New Jersey 08512, US
|
|
|
2015
|
|
|
Clinical Studies, Biotechnology Company, Rare Diseases Therapeutics Development, Gene Therapy, Rare Disease, Pkd, Danon Disease, Fanconi Anemia, Lad-I
|
Mayur Kasetty is the CEO of Rocket Pharmaceuticals. To contact Mayur Kasetty email at [email protected] or [email protected].
The decision makers in Rocket Pharmaceuticals are David Silverstein, Erika A Zannoumantri, Erika A Zannou-mantri, etc. Click to Find Rocket Pharmaceuticals decision makers emails.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.